Plavix Responsiveness: Use of TNFa and genetics.

Trial Profile

Plavix Responsiveness: Use of TNFa and genetics.

Not stated
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2012

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Embolism and thrombosis; Ischaemic heart disorders; Myocardial infarction
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 02 Jun 2012 New source identified and integrated (Oregon Health and Science University Institutional Review Board).
    • 16 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top